Thierens H - Search Results

1

Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.

Lahorte CM, van de Wiele C, Bacher K, van den Bossche B, Thierens H, van Belle S, Slegers G, Dierckx RA. Lahorte CM, et al. Among authors: thierens h. Nucl Med Commun. 2003 Aug;24(8):871-80. doi: 10.1097/01.mnm.0000084585.29433.58. Nucl Med Commun. 2003. PMID: 12869819 Clinical Trial.

2

Accurate dosimetry: an essential step towards good clinical practice in nuclear medicine.

Bacher K, Thierens HM. Bacher K, et al. Nucl Med Commun. 2005 Jul;26(7):581-6. doi: 10.1097/01.mnm.0000169204.13754.e2. Nucl Med Commun. 2005. PMID: 15942477 Review.

3

Patient dosimetry in radionuclide therapy: the whys and the wherefores.

Thierens HM, Monsieurs MA, Bacher K. Thierens HM, et al. Nucl Med Commun. 2005 Jul;26(7):593-9. doi: 10.1097/01.mnm.0000167910.76718.ad. Nucl Med Commun. 2005. PMID: 15942479 Review.

4

Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.

Lahorte CM, Bacher K, Burvenich I, Coene ED, Cuvelier C, De Potter C, Thierens H, Van de Wiele C, Dierckx RA, Slegers G. Lahorte CM, et al. Among authors: thierens h. J Nucl Med. 2004 Jun;45(6):1065-73. J Nucl Med. 2004. PMID: 15181142 Free article.

5

188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial.

Lambert B, Bacher K, Defreyne L, Gemmel F, Van Vlierberghe H, Jeong JM, Dierckx RA, Van de Wiele C, Thierens H, De Vos F. Lambert B, et al. Among authors: thierens h. J Nucl Med. 2005 Jan;46(1):60-6. J Nucl Med. 2005. PMID: 15632035 Free article. Clinical Trial.

6

Biodistribution and dosimetry of (99m)Tc-depreotide (P829) in patients suffering from breast carcinoma.

Van Den Bossche B, D'haeninck E, Bacher K, Thierens H, Van Belle S, Dierckx RA, Van de Wiele C. Van Den Bossche B, et al. Among authors: thierens h. Cancer Biother Radiopharm. 2004 Dec;19(6):776-83. doi: 10.1089/cbr.2004.19.776. Cancer Biother Radiopharm. 2004. PMID: 15665627

7

In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.

Kersemans V, Cornelissen B, Bacher K, Kersemans K, Thierens H, Dierckx RA, De Spiegeleer B, Slegers G, Mertens J. Kersemans V, et al. Among authors: thierens h. J Nucl Med. 2005 Dec;46(12):2104-11. J Nucl Med. 2005. PMID: 16330577 Free article.

8

In vitro and in vivo evaluation of direct rhenium-188-labeled anti-CD52 monoclonal antibody alemtuzumab for radioimmunotherapy of B-cell chronic lymphocytic leukemia.

De Decker M, Bacher K, Thierens H, Slegers G, Dierckx RA, De Vos F. De Decker M, et al. Among authors: thierens h. Nucl Med Biol. 2008 Jul;35(5):599-604. doi: 10.1016/j.nucmedbio.2008.03.001. Nucl Med Biol. 2008. PMID: 18589304

9

Estimation of risk based on biological dosimetry for patients treated with radioiodine.

Monsieurs MA, Thierens HM, van de Wiele CV, Vral AM, Meirlaen IA, de Winter HA, de Sadeleer CJ, de Ridder LI, Kaufman JM, Dierckx RA. Monsieurs MA, et al. Among authors: thierens hm. Nucl Med Commun. 1999 Oct;20(10):911-7. doi: 10.1097/00006231-199910000-00008. Nucl Med Commun. 1999. PMID: 10528296 Clinical Trial.

10

Biodistribution and dosimetry of carbon-11-methoxyprogabidic acid, a possible ligand for GABA-receptors in the brain.

Santens P, De Vos F, Thierens H, Decoo D, Slegers G, Dierckx RA, De Reuck J. Santens P, et al. Among authors: thierens h. J Nucl Med. 1998 Feb;39(2):307-10. J Nucl Med. 1998. PMID: 9476942 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters